Veracyte Adds MRD Capabilities to Diagnostics Platform Following C2i Genomics Acquisition
Veracyte will acquire C2i Genomics, a MRD detection company, adding whole-genome MRD capabilities to its diagnostics platform.
Read More
Search Results for: liver disease
UK Turns to Technology-Centric Strategy to Meet Pathology Challenges
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read More
PanGIA Biotech to Expand Multi-Cancer Early Detection Liquid Biopsy Study
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More
NIH Deploys Picodya’s IVD Platform to Detect Global Viral Threats
Picodya, the creator of a hybrid IVD solution for multiplexed POC testing, announced the deployment of its B-Matrix technology in NIH labs.
Read More
New ChromaCode Collaboration to Improve NSCLC Biomarker Testing Access
ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode’s HDPCR NSCLC biomarker assay.
Read More